Spiegel and Patel Detail Stepwise Migraine Treatment and Aura Diagnosis
- Eye care clinicians can recognize and manage migraine and similar headache disorders through a structured clinical approach outlined by presenters, Managed Healthcare Executive reported.
- A typical visual aura builds gradually over at least five minutes, resolves within 60 minutes, and precedes or accompanies a headache, Patel stated.
- Lifestyle management forms the foundation of every patient treatment plan, Spiegel explained.
Eye care clinicians can recognize and manage migraine and similar headache disorders through a structured clinical approach outlined by presenters, Managed Healthcare Executive reported. Vivek Patel, chief of neuro-ophthalmology services at UCI Health, and Spiegel detailed diagnostic markers and treatment ladders during the presentation.
Visual Auras and Cortical Spreading Depression
A typical visual aura builds gradually over at least five minutes, resolves within 60 minutes, and precedes or accompanies a headache, Patel stated. An aura that follows a headache serves as a red flag for clinicians. This visual disturbance reflects cortical spreading depression, which is a wave of depolarization moving across the visual cortex, though some patients experience the phenomenon without any subsequent headache. Patel noted that migraine represents the most common neurologic cause of photophobia, recommending FL-41 tinted lenses that patients can wear indoors.
Stepwise Migraine Treatment Ladder
Lifestyle management forms the foundation of every patient treatment plan, Spiegel explained. Our brains like consistency,
Spiegel said, emphasizing that maintaining regular sleep and wake times matters more than total hours spent sleeping. Clinical guidance advises protein at every meal, adequate hydration, and 15 minutes of daily exercise that elevates the heart rate. Over-the-counter supplements such as magnesium possess clinical evidence supporting headache frequency reduction and are appropriate for nearly all patients.
For acute attacks, nonsteroidal anti-inflammatory drugs remain the first line of defense, followed by triptans and gepants. Triptans carry a primary contraindication for patients with cardiovascular disease. Treating symptoms at the first sign of aura or pain improves the likelihood of halting an attack, but patients must limit acute abortive medications like Advil to fewer than 10 days per month to prevent medication overuse headaches. Daily preventives, including anti-seizure medications, beta blockers, or nortriptyline, suit patients experiencing frequent or debilitating attacks or those for whom acute therapy fails.
CGRP-targeted preventives and onabotulinumtoxinA for chronic migraine occupy the highest tier of the treatment ladder, Spiegel reported. Because these specialized therapies demand prior authorization and support staff that typical ophthalmology practices lack, and headache clinic wait times span nine to 12 months, Spiegel recommended early referrals alongside initiating lower treatment tiers immediately.
Conditions Mimicking Migraine and Clinical Red Flags
Several less frequent disorders are frequently misdiagnosed as migraine. Trochleitis generates pain near the inner upper eye socket that intensifies with eye movement and touch, absent vision loss. Patel reported that trochleitis responds favorably to an in-office steroid and anesthetic injection near the trochlea, with oral indomethacin or prednisone serving as alternative options.
Red flags mandating diagnostic imaging comprise a new headache emerging after age 50, an altered headache pattern, papilledema, or cranial nerve palsy. Absent these indicators, Spiegel urged eye care clinicians to pursue referrals without hesitation, stating that providers possess a duty to supply patients with tools that improve their daily lives.